We are excited to offer several Product Theaters during the 47th Annual Pulmonary and Allergy Update. Product Theaters present new research findings on pharmaceutical products or disease states, provide product details, and highlight new drug and device approvals.
Please view the Product Theater schedule and additional information below. If you have any questions, please email ProEd@njhealth.org.
All Product Theaters will be held inside the Keystone Conference Center - Torreys Peak 1-2.
Ignite New Thinking in COPD: Exploring Type 2 Inflammation
Wednesday, February 5
7:15—8:15 p.m.
Dinner will be provided
Presenter: Barry Make, MD
Together, we will take a closer look at how Type 2 inflammation is driving COPD exacerbation for some patients. Engage with us to gain insights into identifying Type 2 inflammation and understanding its impact on certain patients with COPD.
Sponsored by Sanofi & Regeneron
AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg): The Paradigm Has Shifted
Thursday, February 6
10:15—11:15 a.m.
Presenter: Daniel Soteres, MD, MPH
Please Join AstraZeneca for an expert-led presentation that may shift your thinking. Our expert will cover efficacy and safety data and how this treatment option may apply to your clinical practice.
Sponsored by AstraZeneca
Product Theater
Thursday, February 6
3:30—4:30 p.m.
Sponsored by AstraZeneca
Two Diseases, One Pathway: Explore a Treatment Option for
Multiple Respiratory Diseases
Friday, February 7
10:15—11:15 a.m.
Lunch will be provided
Presenter: Corinne Young, NP
Join us for an exciting glimpse into a treatment option in respiratory diseases. Develop a deeper understanding of how blocking signaling of key cytokines can impact clinical outcomes in patients.
Sponsored by Sanofi & Regeneron
Hiding In Plain Sight: Inborn Errors of Immunity (IEI)
Friday, February 7
3:30—4:30 p.m.
Presenter: Nicholas Hartog, MD
The presentation starts with an overview of the immune system, followed by a case study highlighting the journey of a Primary Immunodeficiency (PI) patient towards diagnosis. It then provides an introduction to APDS, a progressive form of primary immunodeficiency, and explains how genetic testing can play a crucial role in making a definitive diagnosis of PI.
Sponsored by Takeda Pharmaceuticals
Product Theater
Friday, February 7
6:45—7:45 p.m.
Dinner will be provided
Sponsored by Pharming Healthcare
Not part of the official programming of the 47th Annual National Jewish Health Pulmonary and Allergy Update.
The promotional activities are provided by the identified sponsor and are not certified for continuing education credit. The content of the Product Theaters and opinions expressed by presenters are those of the sponsor or presenters and not of National Jewish Health.